Searle Cytotec Pregnancy Reminder Issued As RU-486 Action Nears

Searle issued a reminder Aug. 23 that its gastric ulcer treatment Cytotec (misoprostol) is contraindicated for use in pregnant women, about a month before FDA action is expected on the pending NDA for mifepristone.

More from Archive

More from Pink Sheet